Amanote Research

Amanote Research

    RegisterSign In

MUTATION OF PIM1 GENE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INHIBITS CELL DEATH THROUGH CHANGE IN SUBCELLULAR LOCALIZATION OF Pim-1 AND INCREASE OF BAD PHOSPHORYLATION

Hematological Oncology - United Kingdom
doi 10.1002/hon.7_2631
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineCancer ResearchOncologyHematology
Date

June 1, 2019

Authors
N. SasakiK. IchimuraM. NaganeA. Tomiyama
Publisher

Wiley


Related search

Primary Central Nervous System Lymphoma

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2018English

Primary Central Nervous System Lymphoma

Contemporary Neurosurgery
2010English

Primary Central Nervous System T-Cell Lymphoma of the Brain

The Open Neurosurgery Journal
2011English

Primary Central Nervous System Lymphoma

Journal of Neurosurgery
SurgeryNeurology
1985English

PIM1 (Pim-1 Oncogene)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2013English

IL-22; Pim-1 (PIM1)

Science-Business eXchange
2014English

Pim-1 (PIM1); PIM2; PIM3

Science-Business eXchange
2009English

The Process of Somatic Hypermutation Increases Polyreactivity for Central Nervous System Antigens in Primary Central Nervous System Lymphoma.

Haematologica
Hematology
2020English

Neurolymphomatosis Appeared Following Primary Central Nervous System Lymphoma

Internal Medicine
Internal MedicineMedicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy